References

1. Bouroncle BA, Wiseman BK, Doan CA: Leukemic reticu-loendotheliosis. Blood 13:609, 1958.

2. Bourquin-Pionquet A, Rouard H, Roudot-Thoraval F et al.: Severe decrease in peripheral blood dendritic cells in hairy cell leukemia. Br J Haematol 116: 595,2002.

3. Kraut E: Clinical manifestations and infectious complications in hairy cell leukemia. BestPract Res Clin Haematol 16:33, 2003.

4. Golomb HM, Catovsky D, Golde D: Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 89:677, 1978.

5. Zakarija A, Peterson L, Tallman M: Splenectomy and treatments of historical interest. Best Pract Res Clin Haematol. 16:57, 2003.

6. Catovsky D: Hairy cell leukemia and prolymphocytic leukemia. Clin Haematol 6:245, 1977.

7. Golomb H, Vardiman J: Response to splenectomy in 65 patients with hairy cell leukemia an evaluation of spleen weight and bone marrow involvement. Blood 61:349, 1983.

8. Anonymous: Consensus resolution: proposed criteria for the evaluation of response to treatment in hairy cell leukemia. Leukemia 1:405, 1987.

9. Quesada J, Reuben J, Manny J, et al.: Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 310:15, 1984.

10. Ahmed S, Rai K: Interferon in the treatment of hairy cell leukemia. Best Pract Res Clin Haematol 16:61, 2003.

11. Ratain M, Golomb HM, Vardiman J, et al.: Relapse after interferon alpha 2b therapy for hairy cell leukemia analysis of prognostic variables. J Clin Oncol 6:1714, 1988.

12. Kraut E: Phase II trials of pentostatin (Nipent) in hairy cell leukemia. Semin Oncol 27(suppl 5):27, 2000.

13. Grever M, Kopecky K, Foucar K, et al.: Randomized comparison of pentostatin versus interferon alfa2a in previously treated patients with hairy cell leukemia. J Clin Oncol 13:974, 1995.

14. Goodman G, Beutler E, Saven A (eds.): Cladribine in the treatment of hairy cell leukemia. Best Pract Res Clin Haematol 16:101, 2003.

15. Bethel C, Sharpe R: Pathology of hairy cell leukemia. Best Pract Res Clin Haematol 16:15, 2003.

16. Tallman M, Hakimian D, Kopecky K, et al.: Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadeno-sine or 2'deoxycoformycin and prediction of early relapse. Clin Cancer Res 5:1665,1999.

17. Matutes E, Meeus K, McLennen K, Catovsky D: The significance of minimal residual disease in hairy cell leukemia treated with deoxycoformycin: a long term fol-lowup study. Br J Haematol 98:375, 1998.

18. Bastie J, Cazals-Hatem D, Daniel M, et al.: Five year fol-lowup after 2-chlorodeoxyadenosine. Leuk Lymphoma 35:555, 1999.

19. Bouroncle B: Thirty five years in the progress of hairy cell leukemia. Leuk Lymphoma 14(suppl 1):1, 1994.

20. Jansen J, Hermans J: Splenectomy in hairy cell leukemia. Cancer 47:2066, 1981.

21. Federico M, Frassoldati A, Lamparelli, et al.: Long term results of alpha interferon as initial therapy and splenec-tomy as consolidation therapy in patients with hairy cell leukemia. Ann Oncol 5:725,1994.

22. Tallman M: Current treatment strategies for patients with hairy cell leukemia. Rev Clin Exp Hematol 64:323, 2002.

23. Flinn I, Kopecky K, Foucar K, et al.: Long term followup of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pento-statin. Blood 96:2981, 2000.

24. Kraut E, Grever M, Bouroncle B: Long term followup of patients with hairy cell leukemia after treatment with 2'deoxycoformycin. Blood 84:4061, 1994.

25. Thomas D, O'Brien S, Bueso-Ramos C: Rituximab in relapsed or refractory hairy cell leukemia. Blood 102:3906, 2003.

26. Kreitman R, Wilson W, Bergeron K, et al.: Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy cell leukemia. N Engl J Med 345:241, 2001.

27. Kraut E, Neff J, Bouroncle B, Grever M: Immunosuppressive effects of pentostatin. J Clin Oncol 8:848, 1990.

28. Seymour J, Kurzrock R, Freireich E, et al.: 2'Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD41lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906, 1994.

29. Au W, Klasa R, Gallagher R, et al.: Second malignancies in patients with hairy cell leukemia in British Columbia: a 20 year experience. Blood 92:1160, 1998.

30. Kampmeier P, Spielberger R, Dickstein J, et al.: Increased incidence of second neoplasms in patients treated with interferon 2b for hairy cell leukemia: a clinical pathologic assessment. Blood 84:3242, 1994.

31. Frassoldati A, Lamparelli T, Federico M, et al.: Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group. Leuk Lymphoma 13:307, 1994.

32. Rubin L, Nelson D: The soluble interleukin 2 receptor biology function and clinical application. Ann Intern Med 113:619, 1990.

33. Arun B, Curt B, Longo D, et al.: Elevations in serum soluble IL2 receptor levels predict relapse in patients with hairy cell leukemia. Cancer J Sci Am 6:21, 2000.

This page intentionally left blank

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment